DERMATA THERAPEUTICS INC - COM NEW (DRMA)

CUSIP: 249845306

Q2 2023 13F Holders as of 30 Jun 2023

Share change
+106,357
SEC-reported price per share
$1.65
Number of holders
8
Value change
+$184,503
Number of buys
6
Number of sells
3

Security key

249845306

Report period

Q2 2023

Institutions

8

Top holders

8

Ownership snapshot

Top reported holders of DRMA - DERMATA THERAPEUTICS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Proehl Investment Venture...
Disclosed value leader
Proehl Investment Venture...
Comparable rows
0/6
Latest evidence
31 Mar 2023
3/4/5 13F Highest disclosed value: $6,973,306 6 rows are not safely comparable across share classes.

Quick read

Proehl Investment Ventures LLC has the largest disclosed position value at $6.97M.

0 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Proehl Investment Ventures LLC's linked filing trail.
Disclosed position value Top 5
Proehl Investment Ventures LLC $6.97M
Thomas Insley $34.4K
RENAISSANCE TECHNOLOGIES LLC $34K
Tower Research Capital LLC (TRC) $7K
UBS Group AG $4.4K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 6 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Proehl Investment Ventures LLC
3/4/5
10%+ Owner
—
mixed-class rows
$6,973,306
2,933,531 shares
mixed-class rows
— 17 Aug 2021
Thomas Insley
3/4/5
Chief Financial Officer
—
denominator unverified
$34,409
14,337 shares
— 17 Aug 2021
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$34,000
26,400 shares
— 31 Mar 2023
Tower Research Capital LLC (TRC)
13F
Company
13F
—
denominator unverified
$7,000
5,808 shares
— 31 Mar 2023
UBS Group AG
13F
Company
13F
—
denominator unverified
$4,444
3,445 shares
— 31 Mar 2023
WELLS FARGO & COMPANY/MN
13F
Company
13F
—
denominator unverified
$1,969
1,526 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
8
Shares
143,536
Rows available
8
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
4
Q2 2023 holders
8
Holder diff
4
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .